🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

parool.nl/ps/viroloog-ag… Lia van der Hoek and her team against COVID-19!!

HONOURs Virus Outbreak Preparedness and COVID-19 youtu.be/5E_Iqlio0i0 via YouTube EU financed, amazing effort, and honoured to host these talents!

Happy to see our work published at PLOS NTDs! We describe an Affimer that inhibits CCHFV NP function and its application in diagnostic assays (ELISA & LFA). Made possible thanks to Barr Lab, Tomlinsonlab@leeds, Avacta, EUROFINS INGENASA & Marie Skłodowska-Curie Actions (HONOURs-ITN) journals.plos.org/plosntds/artic…

The INgezim COVID assays use the SARS-CoV-2 nucleoprotein (N protein) as the antigen for the detection of antibodies to SARS-CoV-2. A quick test developed at EUROFINS INGENASA youtube.com/watch?v=D6YfOS…

Out today in Nature Medicine, a study investigating human adaptive immunity toward the four seasonal coronaviruses. From A Edridge, Hoekepoek and coworkers. #COVID19

Three new virus families found to target human parasites! New HONOURs study out today in Nature Communications from @Kinsella_Cormac, Hoekepoek, @mlcotten13 and collaborators Amsterdam UMC. nature.com/articles/s4146…

This Week in Virology | A podcast about viruses - the kind that make you sick microbe.tv/twiv/

Our ESRs work on viruses crossing borders between humans and animals has been published in several peer-reviewed international journals. From hard core fundamental science to sophisticated assays for detection...check the publications tab in our webpage! 👉🏼honours.eu

Interested in a collaborative PhD between the KU Leuven and GSK on the "The Human Virome in Respiratory and Skin Disorders"? Check out our latest PhD-vacancy: kuleuven.be/personeel/jobs…. Please ReTweet.

In our PLOS Pathogens review we (ESRs from HONOURs-ITN) give an accessible overview of the research and development challenges commonly faced upon the emergence of a novel pathogen, using as example the current #SARSCoV2 outbreak response. Check it out!👉journals.plos.org/plospathogens/…

Yet another great achievement! Looking very much forward to how the story will continue!

Belangrijke nieuwe inzichten in wat misloopt in het afweersysteem van mensen met ernstige COVID. Proficiat Els Wauters Joost Wauters ⁦@DiLa_lab⁩ @PierreVM0 Junbin Qian ⁦Neyts Virology Lab⁩ en vele anderen. Dank voor de fijne samenwerking. pers.uzleuven.be/leuvense-studi…

It has been for a while in the "limbo" but finally got published in Nature! It has been a great collaboration Dave @DewIvcp, Charaf Charaf Benarafa, and Martin Friedrich-Loeffler-Institut ... SARS-CoV-2 spike D614G change enhances replication and transmission nature.com

I feel honored, Thank you! and also a big thank you to all collaborators and funding agencies supporting our efforts! Swiss National Science Foundation HONOURs-ITN

Happy international women's day! nationalgeographic.com/science/articl…

While single-dose #COVID19 vaccines are preferred, two-dose may improve efficacy. Solforosi, Kuipers, Zahn et al. JNJInnovative Medicine show that immunogenicity of Ad26.COV2.S is improved in nonhuman primates after a second dose. bit.ly/3nAD7DJ #Infectiousdisease #hostdefense

The heroic work of @mitragltm, with support of our fantastic colleagues and collaborators, is finally out!! Demonstrating that there is a lot of potential to reduce and refine animal experimentation. wwwnc.cdc.gov/eid/article/27… #3Rs #SARSCoV2 Universität Bern Three Rivers Climate CDC Swiss National Science Foundation HONOURs-ITN

⚠️WEAR MASK EVEN IF VACCINATED—Top World Health Organization (WHO) leader urges masks against #DeltaVariant even if 2-dose vaxxed. "Vaccine alone won't stop community transmission. People need to use masks consistently, be in ventilated spaces—even if you're vaccinated" #COVID19🧵 cnbc.com/2021/06/25/del…

Latest HONOURs-ITN publication out now in Virus Evolution